AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

LEVOCABASTINE

9 registrations across 5 African markets— 6 active

Markets with LEVOCABASTINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
ALLERGIFLASH 0,05% COLLYRE RECIPIENT UNIDOSE BOITE DE 10🇨🇮Côte d'IvoireLABORATOIRE CHAUVINactiveJan 2028
OPTAGEX🇿🇦South AfricaSoflens (Pty) LtdactiveNov 2027
LEVOPHTA 0,05% COLLYRE FLACON DE 5ML🇨🇮Côte d'IvoireLABORATOIRE CHAUVINexpiredMar 2024
ALLERGIFLASH
Collyre / 0.05%
🇹🇳TunisiaCHAUVINexpiredApr 2017
LEVOPHTA
Collyre / 0.05%
🇹🇳TunisiaCHAUVINexpiredMar 2006
LEVOPHTA
collyre / 0,03%
🇸🇳SenegalCHAUVIN FRANCEactive
LEVOPHTA
collyre en suspension / 0,05%
🇸🇳SenegalCHAUVIN FRANCEactive
ALLERGIFLASH
collyre / 0.05 %
🇸🇳SenegalCHAUVINactive
LEVOPHTA
COLLYRE
🇲🇦Moroccoactive

LEVOCABASTINE in Africa — Regulatory Overview

LEVOCABASTINE is registered across 5 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Côte d'Ivoire, Tunisia, Morocco and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.